Welcome to Awesome Blog Design perfect blog
Business, Healthcare

Opdivo (nivolumab) plus chemotherapy show statistically significant improvement in pathologic complete response as neoadjuvant treatment of resectable non-small cell lung cancer in phase 3 CheckMate-816 trial

[contact-form][contact-field label=”Name” type=”name” required=”true” /][contact-field label=”Email” type=”email” required=”true” /][contact-field label=”Website” type=”url” /][contact-field label=”Message” type=”textarea” /][/contact-form] CheckMate –816 met a primary endpoint of improved pathologic complete response in patients who received Opdivo plus chemotherapy before surgery Positive results mark the first time an

Business, Healthcare

Topcon achieves #1 market position in OCT devices

Leads the OCT Market with Innovative Multimodal Technology OAKLAND, N.J.–(BUSINESS WIRE)–#OCT–Topcon Healthcare, a leading provider of medical devices and software solutions for the global eye care community, announced today that it has achieved the #1 position in the global OCT market, as